HHS Forges International Partnership to Address Antimicrobial Resistance
August 3, 2016 | Strategic Insights for Health System
The Department of Health and Human Services (HHS) announced on July 28, 2016, an "unprecedented" international partnership with three other organizations to combat antimicrobial resistance. The partnership, which also includes the Wellcome Trust of London, the United Kingdom's AMR Centre of Alderley Park, and the Boston University School of Law, will be one of the world's largest public–private partnerships focused on discovery and development of antimicrobial products. The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) could provide hundreds of millions of dollars to increase the number of antibiotics over the next five years, HHS said. The partnership will find potential antibiotics and move them through preclinical testing to enable safety and efficacy testing, which will greatly reduce risk for the private sector, HHS said.